World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
17422
World Ranking
2234
National Ranking
1080

Jonathan S. Serody publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jonathan S. Serody sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 326 publications — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jonathan S. Serody D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jonathan S. Serody sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 72 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jonathan S. Serody is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily covers areas within medicine, with significant contributions in immunology and microbiology. The scientist's work is further divided into key subfields such as immunology, oncology, hematology, molecular biology, and genetics.

Their research topics focus extensively on:

  • CAR-T cell therapy research
  • Cancer immunotherapy and biomarkers
  • Immunotherapy and immune responses
  • Immune cell function and interaction
  • Hematopoietic stem cell transplantation
  • Lymphoma diagnosis and treatment
  • Immune cells in cancer

Jonathan S. Serody has published numerous articles in various scientific venues. Their frequent publication outlets include:

  • UNC Libraries
  • Blood
  • Cancer Research
  • Journal of Clinical Oncology
  • Blood Advances

Among their recent papers are:

  • Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma, 2020, Journal of Clinical Oncology
  • B Cell Function in the Tumor Microenvironment, 2022, Annual Review of Immunology
  • STING agonist promotes CAR T cell trafficking and persistence in breast cancer, 2020, The Journal of Experimental Medicine
  • Minimal PD-1 expression in mouse and human NK cells under diverse conditions, 2020, Journal of Clinical Investigation
  • Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia, 2021, Blood Cancer Discovery

Frequent collaborators in their research include:

  • Benjamin G. Vincent
  • Gianpietro Dotti
  • Natalie S. Grover
  • Barbara Savoldo
  • Catherine Cheng

Best Publications

  • The Immune Landscape of Cancer.

    Unknown

  • Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.

    Yuanzeng Min;Kyle C. Roche;Shaomin Tian;Michael J. Eblan

  • Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.

    Steven L. Highfill;Paulo C. Rodriguez;Qing Zhou;Christine A. Goetz

  • B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer.

    Daniel P. Hollern;Nuo Xu;Aatish Thennavan;Cherise Glodowski

  • L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection

    Patricia A. Taylor;Angela Panoskaltsis-Mortari;Jessica M. Swedin;Philip J. Lucas

  • Leukocyte migration and graft-versus-host disease

    Christian A. Wysocki;Angela Panoskaltsis-Mortari;Bruce R. Blazar;Jonathan S. Serody

  • Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

    Michael D. Iglesia;Joel S. Parker;Katherine A. Hoadley;Jonathan S. Serody

  • In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

    Michael J. Carlson;Michelle L. West;James M. Coghill;Angela Panoskaltsis-Mortari

  • Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.

    Carlos A. Ramos;Carlos A. Ramos;Natalie S. Grover;Anne W. Beaven;Premal D. Lulla;Premal D. Lulla

  • B Cell Function in the Tumor Microenvironment.

    Unknown

  • Alternative tumour-specific antigens.

    Christof C. Smith;Sara R. Selitsky;Shengjie Chai;Paul M. Armistead

  • Intravascular Catheter Exchange and Duration of Candidemia

    John H. Rex;John E. Bennett;Alan M. Sugar;Peter G. Pappas

  • Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers.

    Oliver Mt Pearce;Robin M Delaine-Smith;Eleni Maniati;Sam Nichols

  • Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

    Kai Sun;Lisbeth A. Welniak;Angela Panoskaltsis-Mortari;Matthew J. O'Shaughnessy

  • Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer

    Michael D. Iglesia;Benjamin G. Vincent;Joel S. Parker;Katherine A. Hoadley

  • Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease

    Christian A. Wysocki;Qi Jiang;Angela Panoskaltsis-Mortari;Patricia A. Taylor

  • Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma

    Christof C. Smith;Kathryn E. Beckermann;Dante S. Bortone;Aguirre A. De Cubas

  • CSF-1–dependant donor-derived macrophages mediate chronic graft-versus-host disease

    Kylie A. Alexander;Ryan Flynn;Katie E. Lineburg;Rachel D. Kuns

  • Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

    Ryan P Flynn;Jing Du;Rachelle G. Veenstra;Dawn K Reichenbach

  • Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

    Jason A. Dubovsky;Ryan P Flynn;Jing Du;Bonnie K. Harrington

  • Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.

    James M. Coghill;Stefanie Sarantopoulos;Timothy P. Moran;William J. Murphy

  • T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease

    Jonathan S. Serody;Susan E. Burkett;Angela Panoskaltsis-Mortari;Angela Panoskaltsis-Mortari;Angela Panoskaltsis-Mortari;Judith Ng-Cashin

Frequent Co-Authors

Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Angela Panoskaltsis-Mortari
Angela Panoskaltsis-Mortari University of Minnesota
William J. Murphy
William J. Murphy Texas A&M University
Geoffrey R. Hill
Geoffrey R. Hill Fred Hutchinson Cancer Research Center
Patricia A. Taylor
Patricia A. Taylor University of Minnesota
David H. Munn
David H. Munn Augusta University
Leo Luznik
Leo Luznik Johns Hopkins University
Ivan Maillard
Ivan Maillard University of Pennsylvania
Jerome Ritz
Jerome Ritz Harvard University
Kelli P. A. MacDonald
Kelli P. A. MacDonald QIMR Berghofer Medical Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can broaden career opportunities. Nursing programs, especially Licensed Practical Nurse (LPN) paths, provide a solid foundation in patient care. Many students seek accredited lpn programs easy to get into to start their healthcare journey without extensive prerequisites.

Advancing further, Nurse Practitioner (NP) degrees are a popular choice for those aiming to specialize. Prospective students often look for easiest np programs to get into that balance quality education and accessibility, enabling a smooth transition into advanced practice roles.

For those with an interest in mental health linked to immunological research, online Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are highly relevant. Finding programs with the best online pmhnp programs ensures access to quality clinical placements, a crucial part of practical training.

Cost is also a significant factor. Students often prioritize cheapest pmhnp programs online to manage education expenses while gaining necessary qualifications. These options make advanced healthcare education more attainable for many aspiring professionals.

Best Scientists Citing Jonathan S. Serody

Trending Scientists

Recently Published Articles